Neogenomics (NEO) Notes Payables (2024 - 2025)

Neogenomics (NEO) reported Notes Payables of $201.1 million for Q1 2025, little changed quarter-over-quarter from $200.8 million in Q4 2024.

Neogenomics (NEO) Notes Payables (2024 - 2025) Analysis & Trends

Neogenomics has reported Notes Payables for 2 years, with the latest figure at $201.1 million in Q1 2025.

For the quarter ending Q1 2025, Notes Payables changed N/A year-over-year to $201.1 million; the trailing twelve-month figure through Mar 2025 stood at $201.1 million (changed N/A YoY), and the FY2024 full-year result was $200.8 million, changed N/A from the prior year.
Notes Payables for Q1 2025 stood at $201.1 million, roughly flat from $200.8 million in the prior quarter.
The five-year high for Notes Payables was $201.1 million in Q1 2025, with the low at $200.1 million in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	29,902.70 Bn	29,902.24 Bn	1.11 Bn
2	Thermo Fisher Scientific	175.99 Bn	172.74 Bn	7.74 Bn
3	Danaher	129.87 Bn	124.18 Bn	3.59 Bn
4	Idexx Laboratories	44.75 Bn	44.55 Bn	722.74 Mn
5	Agilent Technologies	37.52 Bn	35.72 Bn	990.00 Mn
6	Iqvia Holdings	30.91 Bn	28.94 Bn	1.36 Bn
7	Natera	30.21 Bn	29.11 Bn	696.04 Mn
8	Illumina	24.19 Bn	23.04 Bn	721.00 Mn
9	Mettler Toledo International	23.12 Bn	23.06 Bn	555.82 Mn
10	Neogenomics	1.41 Bn	1.27 Bn	80.86 Mn

Download Data